| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |